Disclosure under Regulation 30 of SEBI LODR, 2015 for details of order received from GST Authority, Gujarat
As filed · Disclosure under Regulation 30 of SEBI LODR, 2015 for details of order received from GST Authority, Gujarat.
What happened
FactRPGLIFE has submitted a filing to the National Stock Exchange of India regarding an order win. The details of the order are enclosed as per the specified SEBI circular. The company requests that this information be recorded.
Why it matters
CapitSignal interpretationAn order converts to revenue over its execution period, so its size relative to existing revenue decides whether it changes the trajectory or is routine flow.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
DelayedIn Q4 FY26, RPG Life Sciences recorded a 23.6% Y-o-Y increase in revenue, along with a healthy EBITDA margin of 25.6%.
Revenue grew 15.8%, EBITDA by 17.9% and margins by 40 bps y-o-y in Q1 FY27
Change
FactImplication
CapitSignal interpretationWatch next
Fact- Execution period stated in the order
- Whether the order book total is disclosed
- Margin commentary at the next results
- On the back of continued robust performance, The Board of Directors has recommended highest ever dividend of 2 (management committed by FY25)
- The Board of Directors at its meeting held today has recommended a Final dividend of Rs 24 per equity share i. (management committed by FY26)
Evidence
- Disclosure under Regulation 30 of SEBI LODR, 2015 for details of order received from GST Authority, Gujarat.(opens the original filing in a new tab)
- Earlier statement · Q4 FY26
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- ORDER_WIN base 58; +5 quantified amount; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%